Singer Capital Markets is delighted to have been appointed as Nominated Advisor and Sole Broker to SkinBioTherapeutics plc with immediate effect.
SkinBioTherapeutics plc is a UK-based life sciences company focused on skin health. Headquartered in Newcastle upon Tyne, the Company focuses on developing products that harness the skin microbiome to improve skin health.
Ticker: SBTX
Market Cap: £43.89 million*
Website: Click here
*As of 20th May 2025
Account Team
| Investment Banking | |||
|---|---|---|---|
 Phil Davies Managing Director,Investment Banking Email | Call |
 Sam Butcher Assistant Director.Investment Banking Email | Call |
 Patrick Weaver Analyst,Investment Banking Email | Call |
|
| Research and Sales | |||
|---|---|---|---|
 Karl Keegan Head of Research Email | Call |
 Jonathan Dighe Equity Sales Email | Call |
||
| Investor Relations | |||
|---|---|---|---|
 Megan Willson Investor Relations Email | Call |
|||
Let’s Talk
If you’re looking for more information about any of our services, or if you can’t find what you’re looking for directly on our site, please do not hesitate to contact us.
